Table 1 Chemical-assisted sequencing methods for single-base resolution mapping of f5C

From: 5-Formylcytosine is not a prevalent RNA modification in mammalian cells

Method

Chemistry & sensitivity (S)

f5C specificity

target RNA

Number of f5C sites reported

Reference

fCAB RNA-seq

O-ethylhydroxylamine & bisulfite treatment

S: low

not tested

mitochondrial-enriched RNA (human)

1 (f5C34 of mt-tRNAMet)

52,53

RedBS RNA-seq

Na-borohydride & bisulfite treatment

S:low

not tested

mitochondrial-enriched RNA (human)

1 (f5C34 of mt-tRNAMet)

52,53

f5C-seq

Pyridine borane (PyBo)

S:high

not tested

poly(A)+ RNA (yeast)

1892

12

Protonation-dependent sequencing

Cyanoborohydride

S: low

ac4C and ca5C cross-reactivity; No cross-reactivity with m5C, hm5C and C

mt-tRNAMet (human)

1 (f5C34 of mt-tRNAMet)

54

Mal-seq

Malononitrile (Mal)

S: low

no cross-reactivity with m5C and hm5C

mt-tRNAMet (human, mouse, yeast, Drosophila, C. elegans)

human, mouse, C. elegans: 1 (f5C34 of mt-tRNAMet), yeast and Drosophila: 0

29

f5C-seq

2-picoline borane (PiBo)

S: high

not tested

small RNA, poly(A)+ RNA, chromatin-associated RNA (caRNA) of human and mouse cells

human and mouse small RNA: 2 (f5C34 of mt-tRNAMet and f5C/f5Cm34 of ct-tRNALeu); poly(A)+ RNA: >100, caRNA: 3 sites in human and mouse, respectively

30

FIBo-seq

Immunoprecipitation & PyBo

S: high

high

rRNA-depleted RNA from mESCs

1 (f5C34 of mt-tRNAMet)

This study